Drugs of Abuse Testing Devices Market 2021- Impact of COVID-19 | Biggest Innovations and Future Technologies by F. Hoffmann La-Roche, Siemens Healthineers, Thermo Fisher Scientific, Alere, Shimadzu, Laboratory Corporation of America Holdings, Dragerwerk,

Drugs of abuse testing are an advanced technique for detecting an illegal or prescribed substance in the sample such as hair, blood, urine, saliva, or sweat. This process includes the screening test followed by the identification of drugs present in the sample. This test can be used for medical screening, forensic data, pain medication, and athletics testing. Overall, the drugs of abuse testing focus on the identification of drugs or combination of drugs a person is receiving for proper treatment. Sample collection devices, an expansive test menu, compact bench-top clinical analyzers, and data management options are some of the major devices of drugs of abuse testing.

Get Sample Research Report- https://www.stratagemmarketinsights.com/sample/9425

A growing number of people consuming alcohol and illicit drugs such as marijuana and cocaine is predominantly fueling the growth of Asia Pacific drugs of abuse testing market. According to the report published by India Today in June 2019, the surveys in India in 2018 and Nigeria in 2017 have offered great insights into drug consumption due to being such vast demographics for their region. India accounts for 30 percent of the population in Asia alone. The report reveals that of the 271 million people that used any drug, 35 million (nearly 13 percent) suffer from a drug use disorder.

On the other hand, lack of awareness regarding the drug testing across certain countries of Asia Pacific is expected to restrict the growth of the drug abuse testing market

Key Developments:

• In January 2019, two new urine drug screens received approval for quick In-Office Testing. The iCUP Rx Drug Screen, introduced by Alere (Waltham, Massachusetts), delivers drug levels for five of the most commonly abused opioid-derived drugs. The second new test, the Sefria Drug Screening Kit, is the first and only available in-office product to enable physicians to monitor for the presence of fentanyl; the Sefria kit is available from Immunalysis Corporation, a division of Alere.

• In January 2020, Siemens Healthineers is now distributing the ARK™ Fentanyl Assay, providing laboratories with a greater window to screen for fentanyl to more effectively triage patients who have been exposed to the dangerous opioid.

• In April 2018, Ortho Clinical Diagnostics, Raritan, NJ, has announced an international distribution and co-promotion agreement with Thermo Fisher Scientific, Waltham, Mass, to offer 14 assays for use in monitoring therapeutic drugs, immunosuppressive drugs, and drugs of abuse.

• In February 2017, the Bartholomew County Sheriff’s Department in Indiana received approval to buy a TruNarc Handheld Narcotics Analyzer. The device has the capability to test for 370 illicit substances without requiring police to open any packaging that may be around the suspected substance.

Geographically, this report split Asia-Pacific into several key Regions, with sales (Units), Revenue (Million USD), market share and growth rate of Drugs of Abuse Testing Devices for these regions, from 2014 to 2025 (forecast), including

⤍ China
⤍ Japan
⤍ South Korea
⤍ Taiwan
⤍ India
⤍ Southeast Asia
⤍ Australia

Asia-Pacific Drugs of Abuse Testing Devices market competition by top manufacturers/players, with Drugs of Abuse Testing Devices sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

⤍ F. Hoffmann La-Roche
⤍ Siemens Healthineers
⤍ Thermo Fisher Scientific
⤍ Alere
⤍ Shimadzu
⤍ Laboratory Corporation of America Holdings
⤍ Dragerwerk
⤍ Express Diagnostics International

On the basis of product, this report displays the sales volume (Units), Revenue (Million USD), product price (USD/Unit), market share and growth rate of each type, primarily split into

⤍ Saliva Testing
⤍ Breath Testing
⤍ Urine Testing
⤍ Blood Testing
⤍ Hair & Sweat Testing
⤍ Other

Buy Now- https://www.stratagemmarketinsights.com/cart/9425

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume (Units), market share and growth rate of Drugs of Abuse Testing Devices for each application, including

⤍ Hospitals
⤍ Diagnostics Laboratories
⤍ On-the-spot Testing
⤍ Forensic Laboratories
⤍ Other

** NOTE: If you have any special requirements, please let us know and we will offer you the report as you want.

Contact Us:
Mr. Shah
Stratagem Market Insights
Tel: US +1 415 871 0703 / JAPAN +81-50-5539-1737
Email: sales@stratagemmarketinsights.com
Explore By- SK

About Stratagem Market Insights:

Stratagem Market Insights is a management consulting organization providing market intelligence and consulting services worldwide. We bring the expertise of consultants with an cumulative industry experience of more than 70 years. The firm has been providing quantified B2B research and currently offers services to over 350+ customers worldwide. Our reports cover various end-use industries such as Aerospace and Defense, Agriculture, Food and Beverages, Automotive, Chemicals and Materials, Consumer Goods and Retail, Electronics, Energy, Mining, and Utilities, Pharmaceuticals, Manufacturing and Construction, Services, and Healthcare, and ICT.

This release was published on openPR.